Does a Large (>24 mm) Follicle Yield a Competent Oocyte/Embryo?


Journal

Gynecologic and obstetric investigation
ISSN: 1423-002X
Titre abrégé: Gynecol Obstet Invest
Pays: Switzerland
ID NLM: 7900587

Informations de publication

Date de publication:
2020
Historique:
received: 05 06 2020
accepted: 30 07 2020
pubmed: 24 9 2020
medline: 10 4 2021
entrez: 23 9 2020
Statut: ppublish

Résumé

To evaluate the effect of large follicular size (≥24 mm) at day of oocyte retrieval on oocyte/embryo quality. A cohort study was conducted in a single tertiary medical center between July 2018 and May 2019. Before ultrasound-guided follicular aspiration, follicles were measured and divided into 2 groups according to their maximal dimensional size: large: ≥24 mm and normal: <24 mm. Microscopic examination of the follicular aspirates was performed by an embryologist. Each follicle aspirated was evaluated for oocyte maturation, oocyte fertilization, and embryo quality. 428 follicles were measured, including 383 (62.81%) in the normal and 45 (14.06%) in the large follicle groups. Oocytes were achieved during aspiration from 297 (75.5%) and 29 (64.4%) of the normal and large follicle groups, respectively (p = 0.05). No in-between group differences were observed in mature oocyte (MII), fertilization, and top-quality embryo (TQE) rates. Nevertheless, once a zygote (2PN) was achieved, a trend toward a higher TQE rate/2PN was found in the large follicle group (16/19 [84.2%] vs. 115/171 [67.3%]; p = 0.062). While a nonsignificant decrease in oocyte recovery rate was found in follicles ≥24 mm, the zygote and TQE per follicle were comparable.

Identifiants

pubmed: 32966987
pii: 000510876
doi: 10.1159/000510876
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

416-419

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Raoul Orvieto (R)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Aya Mohr-Sasson (A)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Shlomit Blumenfeld (S)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ravit Nahum (R)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Adva Aizer (A)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.

Jigal Haas (J)

Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel, jigalh@hotmail.com.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel, jigalh@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH